Alpine Global Management’s Immunome IMNM Stock Holding History

Alpine Global Management’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-51,178	Closed	-$619K	–	292
2024 Q2	$619K	Sell	51,178 -91,119	-64%	-$1.43M	0.11%	158
2024 Q1	$3.51M	Sell	142,297 -50,036	-26%	-$1.02M	0.68%	29
2023 Q4	$2.06M	Sell	192,333 -173,638	-47%	-$1.44M	0.56%	39
2023 Q3	$3.06M	Hold	365,971	–	–	0.7%	22
2023 Q2	$2.89M	Hold	365,971	–	–	0.8%	27
2023 Q1	$1.83M	Sell	365,971 -352,264	-49%	-$1.72M	0.71%	25
2022 Q4	$1.58M	Hold	718,235	–	–	0.53%	25
2022 Q3	$3.19M	Hold	718,235	–	–	0.75%	30
2022 Q2	$2.31M	Sell	718,235 -159,000	-18%	-$579K	0.58%	41
2022 Q1	$5.08M	Buy	877,235 +15,064	+2%	+$113K	1.15%	18
2021 Q4	$11.2M	Buy	862,171 +7,500	+0.9%	+$134K	1.64%	6
2021 Q3	$20.8M	Hold	854,671	–	–	4.72%	3
2021 Q2	$14.8M	Buy	854,671 +58,962	+7%	+$1.3M	2.01%	15
2021 Q1	$27M	Buy	795,709 +5,501	+0.7%	+$137K	2.58%	10
2020 Q4	$7.65M	Buy	+790,208	New	+$9.22M	1.55%	15

Other funds holding IMNM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Alpine Global Management's IMNM Position: Q3 2024 in Review

Alpine Global Management sold out of Immunome (IMNM) in Q3 2024, closing a stake of 51,178 shares — an estimated $619K sold.

Alpine Global Management first reported a position in IMNM in Q4 2020 and held it in 15 quarters. The position peaked at $27M in Q1 2021. 115 funds tracked by Wall St. Rank hold IMNM as of Q3 2024.

Alpine Global Management reported no remaining Immunome position as of Q3 2024 after selling out during the quarter.
Alpine Global Management sold 51,178 Immunome shares in Q3 2024, an estimated $619K.
Alpine Global Management first reported a position in Immunome in Q4 2020 and held it in 15 quarters.
Alpine Global Management's Immunome position peaked at $27M in Q1 2021.
115 funds tracked by Wall St. Rank held Immunome as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.